At a Glance
| MXiPr | Diarylethylamines | |
|---|---|---|
| Class | Dissociatives | Dissociatives |
| Routes | insufflatedoral | |
| Effects | 53 documented | 8 documented |
Dosage
Only in MXiPr
insufflated
| Level | Dose |
|---|---|
| Threshold | 5 mg |
| Light | 10–20 mg |
| Common | 20–40 mg |
| Strong | 40–60 mg |
| Heavy | 60 mg |
oral
| Level | Dose |
|---|---|
| Threshold | 5 mg |
| Light | 10–20 mg |
| Common | 20–40 mg |
| Strong | 40–60 mg |
Duration
Only in MXiPr
insufflated
Total: 1.5 hrs – 4 hrsAfterglow
Onset2 min – 5 min
Afterglow2 hrs – 12 hrs
oral
Total: 2 hrs – 5 hrsAfterglow
Onset20 min – 1 hrs
Effects
Shared Effects6
Safety
Interaction: MXiPr + Diarylethylamines
No direct interaction data available between these substances. This does not mean the combination is safe.
Frequently Asked Questions
What is the difference between MXiPr and Diarylethylamines?
MXiPr is classified as a Dissociatives (Arylcyclohexylamines) while Diarylethylamines is classified as a Dissociatives . They share 6 effects in common, with 47 effects unique to MXiPr and 2 unique to Diarylethylamines.
Is it safe to combine MXiPr and Diarylethylamines?
There is no direct interaction data available for combining MXiPr and Diarylethylamines. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, MXiPr or Diarylethylamines?
MXiPr and Diarylethylamines are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.